ADIPOQ and breast carcinoma: Adiponectin was inversely associated with breast cancer incidence in some prior prospective investigations [86,104] but not in other studies [84,85], although three recent meta-analyses that included both prospective cohort and case-control studies reported an inverse relationship between adiponectin levels and breast cancer risk [105,106,107].